The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.
Effects of Dietary Weight Loss on Sympathetic Activity and Cardiac Risk Factors Associated with the Metabolic Syndrome
Abstract
CONTEXT: Weight reduction, the first line treatment for the metabolic syndrome, improves insulin sensitivity and associated metabolic and cardiovascular abnormalities, but there is a paucity of data regarding its effect on sympathetic nervous system (SNS) activity in this clinical setting. OBJECTIVES: The objectives of this study were to test the hypothesis that dietary weight loss attenuates both insulin resistance and SNS activity and to examine the relationships between SNS activity and metabolic syndrome (MetS) components. DESIGN: This was a single-sample, repeated measures design study. SETTING: This study was performed at a tertiary referral center. PARTICIPANTS: Twenty-three MetS subjects (age, 58 +/- 2 yr; body mass index, 33.3 +/- 0.8 kg/m2; mean +/- sem) were studied. INTERVENTION: A hypocaloric modified Dietary Approaches to Stop Hypertension diet (26% fat, 22% protein, and 51% carbohydrate; 100 mmol/d sodium) was consumed for 3 months. MAIN OUTCOME MEASURES: The main outcome measures were postganglionic muscle sympathetic nerve activity (microneurography at a peroneal nerve), whole-body plasma norepinephrine spillover rate, spontaneous cardiac baroreflex function, and insulin sensitivity. RESULTS: The hypocaloric diet significantly reduced body weight by 7% and improved all MetS components. Norepinephrine spillover decreased from 877 +/- 180 to 503 +/- 39 ng/min (P = 0.005), and muscle sympathetic nerve activity decreased from 40.6 +/- 2.1 to 34.6 +/- 2.4 bursts/min (P = 0.01), whereas cardiac baroreflex sensitivity increased by 23.0 +/- 8.0% (P = 0.02). The change in the norepinephrine spillover rate correlated positively and independently with the change in plasma leptin concentration (r = 0.49; P = 0.03). CONCLUSION: Weight loss by a hypocaloric diet with moderate sodium restriction diminishes SNS activity in MetS subjects. This may be due to the consequences of decreased leptin concentration, enhanced insulin sensitivity, or improvements in cardiac baroreflex function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“During diet-induced weight loss, the decreases in sympathetic activity are accompanied by reduction in all components of the metabolic syndrome70.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure
Appel, L. J., Moore, T. J., Obarzanek, E., Vollmer, W. M., Svetkey, L. P., Sacks, F. M., Bray, G. A., Vogt, T. M., Cutler, J. A., Windhauser, M. M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361601 · Cited by 5,981
Matsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621
Malik, S., Wong, N. D., Franklin, S. S., Kamath, T. V., L'Italien, G. J., Pio, J. R., & Williams, G. R. (2004) · Circulation · doi:10.1161/01.cir.0000140677.20606.0e · Cited by 1,837
Prospective Analysis of The Insulin-Resistance Syndrome (Syndrome X)
Haffner, S. M., Valdez, R. A., Hazuda, H. P., Mitchell, B. D., Morales, P. A., & D, M. P. S. M. (1992) · Diabetes · doi:10.2337/diab.41.6.715 · Cited by 1,234
The metabolic syndrome: prevalence in worldwide populations
Cameron, A. J., Shaw, J. E., & Zimmet, P. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.005 · Cited by 1,031
Sympathetic Neural Activation in Visceral Obesity
Alvarez, G. E., Beske, S. D., Ballard, T. P., & Davy, K. P. (2002) · Circulation · doi:10.1161/01.cir.0000041244.79165.25 · Cited by 557
Layman, D. K., Boileau, R. A., Erickson, D. J., Painter, J. E., Shiue, H., Sather, C., & Christou, D. D. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.2.411 · Cited by 541
Flagged first, then by citations
2 of the 43 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 226
Casanova‐Lizón, A., Manresa‐Rocamora, A., Flatt, A. A., Sarabia, J. M., & Moya‐Ramón, M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192113899 · Cited by 37
Masuki, S., Mori, M., Tabara, Y., Miki, T., Sakurai, A., Morikawa, M., Miyagawa, K., Higuchi, K., & Nosé, H. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.147728 · Cited by 31
Sympathetic overdrive in the metabolic syndrome: meta-analysis of published studies
Trevano, F. Q., Dell’Oro, R., Biffi, A., Seravalle, G., Corrao, G., Mancia, G., & Grassi, G. M. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002288 · Cited by 33
Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition
Herat, L. Y., Matthews, J. R., Azzam, O., Schlaich, M. P., & Matthews, V. B. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01170-z · Cited by 31
Curry, T. B., Somaraju, M., Hines, C. N., Groenewald, C. B., Miles, J. M., Joyner, M. J., & Charkoudian, N. (2013) · Obesity · doi:10.1002/oby.20106 · Cited by 30
Sympathetic activity in obesity: a brief review of methods and supportive data
Lambert, G. W., Schlaich, M. P., Eikelis, N., & Lambert, É. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14140 · Cited by 31
Self-citationIndependent Evolution of Heart Autonomic Function and Insulin Sensitivity During Weight Loss
Bobbioni‐Harsch, E., Sztajzel, J. M., Barthassat, V., Makoundou, V., Gastaldi, G., Sievert, K., Chassot, G., Huber, O., Morel, P., Assimacopoulos‐Jeannet, F., et al. (2008) · Obesity · doi:10.1038/oby.2008.532 · Cited by 30
Krishnamoorthy, Y., Rajaa, S., Murali, S., Sahoo, J., & Kar, S. S. (2022) · Preventing Chronic Disease · doi:10.5888/pcd19.210231 · Cited by 29
Central mechanisms in sympathetic nervous dysregulation in obesity
Patel, M., Braun, J., Lambert, G. W., Kameneva, T., Keatch, C., & Lambert, É. (2023) · Journal of Neurophysiology · doi:10.1152/jn.00254.2023 · Cited by 35
Self-citationRoles of Beta2‐ and Beta3‐Adrenoceptor Polymorphisms in Hypertension and Metabolic Syndrome
Masuo, K. (2010) · International Journal of Hypertension · doi:10.4061/2010/832821 · Cited by 29
Self-citationCARDIOVASCULAR AND METABOLIC EFFECTS OF OBESITY
Morris, M. J. (2008) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2008.04912.x · Cited by 29
Pontiroli, A. E., Merlotti, C., Veronelli, A., & Lombardi, F. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0454-1 · Cited by 28
Raskin, P., & Cincotta, A. H. (2015) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2016.1131119 · Cited by 28
Christou, G. A., & Kiortsis, D. N. (2017) · Obesity Reviews · doi:10.1111/obr.12501 · Cited by 27
Impact of Obesity and Bariatric Surgery on Cardiovascular Disease
Mathier, M. A., & Ramanathan, R. C. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.02.002 · Cited by 27
Differential sympathetic activation in muscle and skin neural districts in the metabolic syndrome
Grassi, G. M., Quarti‐Trevano, F., Seravalle, G., Dell’Oro, R., Dubini, A., & Mancia, G. (2009) · Metabolism · doi:10.1016/j.metabol.2009.04.028 · Cited by 26
Modest weight loss in moderately overweight postmenopausal women improves heart rate variability
Mouridsen, M. R., Bendsen, N. T., Astrup, A. V., Haugaard, S. B., Binici, Z., & Sajadieh, A. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312444367 · Cited by 26
Sex differences in the sympathoexcitatory response to insulin in obese rats: role of neuropeptide Y
Shi, Z., Cassaglia, P. A., Pelletier, N. E., & Brooks, V. L. (2019) · The Journal of Physiology · doi:10.1113/jp277517 · Cited by 25
Beltaifa, L., Chaouachi, A., Zérifi, R., Boussaidi, L., Bouzrati, I., Abid, A., Elkhadi, A., Chamari, K., & Raies, A. M. (2011) · Obesity Facts · doi:10.1159/000324579 · Cited by 25
Prehypertension: Demographics, pathophysiology, and treatment
Izzo, J. L. (2007) · Current Hypertension Reports · doi:10.1007/s11906-007-0049-8 · Cited by 25
Accessing Autonomic Function Can Early Screen Metabolic Syndrome
Sun, K., Liu, Y., Dai, M., Li, M., Yang, Z., Xu, M., Xu, Y. H., Lu, J., Chen, Y., Liu, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043449 · Cited by 24
Straznicky, N. E., Grima, M. T., Sari, C. I., Lambert, É., Phillips, S. E., Eikelis, N., Mariani, J. A., Kobayashi, D., Hering, D., Dixon, J. B., et al. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00516 · Cited by 24
Self-citationLambert, É., Sari, C. I., Eikelis, N., Phillips, S. E., Grima, M. T., Straznicky, N. E., Dixon, J. B., Esler, M., Schlaich, M. P., Head, G. A., et al. (2017) · Obesity · doi:10.1002/oby.21962 · Cited by 24
Self-citationIs it time to think about the sodium glucose co‐transporter 2 sympathetically?
Elliott, R. H., Matthews, V. B., Rudnicka, C., & Schlaich, M. P. (2016) · Nephrology · doi:10.1111/nep.12620 · Cited by 23
Rosiglitazone Improves Insulin Sensitivity and Baroreflex Gain in Rats with Diet-Induced Obesity
Zhao, D., McCully, B. H., & Brooks, V. L. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.194738 · Cited by 23
Baroreflex sensitivity is impaired in essential hypertensives with central obesity
Colle, S. D., Milan, A., Caserta, M. A., Dematteis, A., Naso, D., Mulatero, P., Rabbia, F., & Veglio, F. (2007) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002163 · Cited by 23
Sites and sources of sympathoexcitation in obese male rats: role of brain insulin
Shi, Z., Zhao, D., Cassaglia, P. A., & Brooks, V. L. (2020) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00317.2019 · Cited by 24
Autonomic nervous system activity and inflammation: good ideas, good treatments, or both?
Chobanyan-Jürgens, K., & Jordan, J. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00826.2015 · Cited by 23
Gonçalinho, G. H. F., Roggério, A., Góes, M. F. S., Avakian, S. D., Leal, D. P., Strunz, C. M. C., & Mansur, A. D. P. (2021) · Molecules · doi:10.3390/molecules26113168 · Cited by 22
Karstoft, K., Brinkløv, C. F., Thorsen, I. K., Nielsen, J. S., & Ried‐Larsen, M. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00132 · Cited by 23
Sympathetic Vasomotor Tone Determines Blood Pressure Response to Long-Term Sibutramine Treatment
Heusser, K., Engeli, S., Tank, J., Diedrich, A., Wiesner, S., Janke, J., Luft, F. C., & Jordan, J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2499 · Cited by 22
Straznicky, N. E., Lambert, E. A., Grima, M. T., Eikelis, N., Richards, K., Nestel, P. J., Dawood, T., Masuo, K., Sari, C. I., Dixon, J. B., et al. (2014) · Obesity · doi:10.1002/oby.20614 · Cited by 21
Self-citationRašić-Milutinović, Z., Miličević, D., Milovanovic, B. D., Peruničić-Peković, G., & Pencic, B. D. (2010) · Saudi Medical Journal · doi:10.15537/1658-3175.5052 · Cited by 21
Adams, S. T., Salhab, M., Hussain, Z., Miller, G. V., & Leveson, S. H. (2012) · Blood Pressure · doi:10.3109/08037051.2012.749570 · Cited by 21
Grassi, G. M., Padmanabhan, S., Menni, C., Seravalle, G., Lee, W. K., Bombelli, M., Brambilla, G., Quarti‐Trevano, F., Giannattasio, C., Cesana, G., et al. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328346d72c · Cited by 21
Internet of Things (IoT) System and Field Sensors for Exercise Intensity Measurements
Masuki, S., Morikawa, M., & Nosé, H. (2020) · Comprehensive physiology · doi:10.1002/cphy.c190010 · Cited by 25
Al-Tahami, B. A. M., Ismail, A. A. A.-S., Bee, Y. T. G., Awang, S. A., Rani, W. R. W. A., Sanip, Z., & Rasool, A. H. G. (2015) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-131765 · Cited by 20
Study on autonomic dysfunction and metabolic syndrome in Chinese patients
Zhu, L., Zhao, X., Zeng, P., Zhu, J., Yang, S., Liu, A., & Song, Y. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12524 · Cited by 20
McGee, T. L., Grima, M. T., Hewson, I., Jones, K., Duke, E. B., & Dixon, J. B. (2011) · Obesity · doi:10.1038/oby.2011.303 · Cited by 20
Obesity in Chronic Kidney Disease: Good or Bad?
Axelsson, J. (2008) · Blood Purification · doi:10.1159/000110559 · Cited by 20
Özçelik, O., Özkan, Y., Algül, Ş., & Çolak, R. (2015) · Patient Preference and Adherence · doi:10.2147/ppa.s84297 · Cited by 18
Reliability of heart rate as neuroadrenergic marker in the metabolic syndrome
Trevano, F. Q., Seravalle, G., Macchiarulo, M., Villa, P., Valena, C., Dell’Oro, R., Mancia, G., & Grassi, G. M. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001370 · Cited by 18
Sympathetic modulation as a goal of antihypertensive treatment: from drugs to devices
Grassi, G. M. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003538 · Cited by 17
The Role of Sympatho-Inhibition in Combination Treatment of Obesity-Related Hypertension
Carnagarin, R., Gregory, C., Azzam, O., Hillis, G. S., Schultz, C. J., Watts, G. F., Bell, D. A., Matthews, V. B., & Schlaich, M. P. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0795-1 · Cited by 17
Sympathetic Neural Control in Humans with Anxiety‐Related Disorders
Bigalke, J. A., & Carter, J. R. (2021) · Comprehensive physiology · doi:10.1002/cphy.c210027 · Cited by 29
Leptin and Associated Neural Pathways Underlying Obesity‐Induced Hypertension
Laule, C. F., & Rahmouni, K. (2024) · Comprehensive physiology · doi:10.1002/cph4.8 · Cited by 19
Lipid abnormalities in pre-eclampsia:implications for vascular health
Kaaja, R. (2011) · Clinical Lipidology · doi:10.2217/clp.10.82 · Cited by 16
Bariatric surgery: results in obesity and effects on metabolic parameters
Clifton, P. M. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328340b8fd · Cited by 15
Angeli, F., Reboldi, G., & Verdecchia, P. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283625055 · Cited by 15
Lambert, G. W., Patel, M., & Lambert, É. (2025) · Metabolites · doi:10.3390/metabo15050286 · Cited by 15
Self-citationObesity and the renin– angiotensin–aldosterone system
Sharma, A. M., & Engeli, S. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.2.255 · Cited by 15
Nestel, P. J., Khan, A. A., Straznicky, N. E., Mellett, N. A., Jayawardana, K. S., Mundra, P. A., Lambert, G. W., & Meikle, P. J. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.11.032 · Cited by 13
Self-citationSimple Exercise Recovery Index for Sympathetic Overactivity Is Linked to Insulin Resistance
Yeckel, C. W., Gulanski, B., Zgorski, M., DZIURA, J., Parish, R., & Sherwin, R. S. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31818afa2f · Cited by 13
Obesity and Atrial Fibrillation: From Mechanisms to Treatment
Dziano, J. K., Ariyaratnam, J., Middeldorp, M. E., Sanders, P., & Elliott, A. D. (2025) · Heart Lung and Circulation · doi:10.1016/j.hlc.2025.08.003 · Cited by 14
Park, D. H., Cho, J. J., Yoon, J. L., Kim, M. Y., & Ju, Y. (2020) · Korean Journal of Family Medicine · doi:10.4082/kjfm.18.0134 · Cited by 12
Consumo de sódio e síndrome metabólica: uma revisão sistemática
Sarno, F., Jaime, P. C., Ferreira, S. R. G., & Monteiro, C. A. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000500013 · Cited by 11
Blood pressure reduction after gastric bypass surgery is explained by a decrease in cardiac output
van Brussel, P. M., van den Bogaard, B., de Weijer, B. A., Truijen, J., Krediet, C. T. P., Janssen, I. M. C., van de Laar, A. W. J. M., Kaasjager, K. A. H., Fliers, E., LIESHOUT, J. J. V., et al. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00362.2016 · Cited by 12
Iida, H., Kurita, N., Takahashi, S., Sasaki, S., Nishiwaki, H., Omae, K., Yajima, N., Fukuma, S., Hasegawa, T., Fukuhara, S., et al. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13593 · Cited by 13
Plasma lipocalin-2/NGAL is stable over 12 weeks and is not modulated by exercise or dieting
Nakai, M. E., Denham, J., Prestes, P. R., Eikelis, N., Lambert, É., Straznicky, N. E., Schlaich, M. P., Esler, M., O’Brien, B. J., Charchar, F. J., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-83472-x · Cited by 12
Self-citationCarnagarin, R., Kiuchi, M. G., Goh, G. S., Adams, L. A., Cohen, N. D., Kavnoudias, H., Gan, S. K., van Schie, G., Esler, M., Matthews, V. B., et al. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002839 · Cited by 11
Self-citationEffects of bariatric surgery on cardiorespiratory fitness: A systematic review and meta‐analysis
Ibacache-Saavedra, P., Jerez‐Mayorga, D., Carretero‐Ruiz, A., Miranda‐Fuentes, C., Cano-Cappellacci, M. A., & Artero, E. G. (2021) · Obesity Reviews · doi:10.1111/obr.13408 · Cited by 11
Cincotta, A. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713255 · Cited by 11
Ibacache-Saavedra, P., Cárcamo, P., Miranda‐Fuentes, C., Bottinelli, A., Guzmán, J., Martínez‐Rosales, E., Artero, E. G., & Cano-Cappellacci, M. A. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04721-y · Cited by 11
Case, H. S., Reed, H. L., Palinkas, L. A., Reedy, K. R., Do, N., Finney, N. S., & Seip, R. L. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02588.x · Cited by 11
Altered responsiveness of the kidney to activation of the renal nerves in fat-fed rabbits
Michaels, S., Eppel, G. A., Burke, S. L., Head, G. A., Armitage, J. A., Carroll, J. F., Malpas, S. C., & Evans, R. G. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90931.2008 · Cited by 11
Chen, Q.-Y., Khil, J., & Keum, N. (2024) · Nutrients · doi:10.3390/nu16070963 · Cited by 12
Chaudhary, P., & Schreihofer, A. M. (2018) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00195.2018 · Cited by 10
The sympathetic neurons in the gut: Perspectives on metabolic and immune health and diseases
Wan, Y., Cao, C., & Zeng, W. (2025) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2025.103051 · Cited by 11
Hong, J. W., Noh, J. H., & Kim, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168527 · Cited by 8
Parasiliti‐Caprino, M., Obert, C., Lopez, C., Bollati, M., Bioletto, F., Bima, C., Egalini, F., Berton, A. M., Prencipe, N., Settanni, F., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10091967 · Cited by 8
Kario, K., Saito, I., Kushiro, T., Teramukai, S., Mori, Y., Hiramatsu, K., Kobayashi, F., & Shimada, K. (2013) · Journal of Clinical Hypertension · doi:10.1111/jch.12132 · Cited by 8
Brain Defense of Glycemia in Health and Diabetes
Mirzadeh, Z., & Faber, C. L. (2024) · Diabetes · doi:10.2337/dbi24-0001 · Cited by 8
Gallo‐Villegas, J., Pérez-Idárraga, A., Valencia-Gómez, K., Castro, D. A. P., Arenas-Sosa, M. M., Velásquez, M. A. Q., & Aristizábal-Ocampo, D. (2016) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2016.01.033 · Cited by 7
Sympathetic Neural Control in Humans with Anxiety‐Related Disorders
Bigalke, J. A., & Carter, J. R. (2021) · Comprehensive physiology · doi:10.1002/j.2040-4603.2022.tb00206.x · Cited by 6
Yambe, T., Sugita, N., & Yoshizawa, M. (2009) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2009.5332644 · Cited by 6
Autonomic Nervous System: Metabolic Function
Straznicky, N. E., Nestel, P. J., & Esler, M. (2009) · Elsevier eBooks · doi:10.1016/b978-008045046-9.00638-0 · Cited by 9
Self-citationRole of Sympathetic Nervous System in the Metabolic Syndrome and Sleep Apnea
Seravalle, G., & Grassi, G. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-420168-2.00018-1 · Cited by 5
Zhernakova, Y. V. (2023) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2023-5681 · Cited by 5
Sympathetic Responses to Antihypertensive Treatment Strategies
Dell’Oro, R., Quarti‐Trevano, F., Ambrosino, P., & Grassi, G. M. (2025) · Current Hypertension Reports · doi:10.1007/s11906-025-01339-2 · Cited by 5
Paknahad, Z., Vasmehjani, A. A., & Maracy, M. R. (2014) · Advanced Biomedical Research · doi:10.4103/2277-9175.137873 · Cited by 5
Metabolic syndrome: what changed during last 30 years?
Татарчук, Т. Ф., Tutchenko, T. М., Perekhrestenko, O. V., Калашніков, О. О., & Glamazda, M. (2018) · Reproductive Endocrinology · doi:10.18370/2309-4117.2018.43.15-27 · Cited by 4
Lifestyle Modification Is the First Line Treatment for Type 2 Diabetes
Masuo, K. (2013) · InTech eBooks · doi:10.5772/56377 · Cited by 3
Self-citationLee, Y.-J., Kim, H., Jang, Y.-N., Han, Y.-M., Seo, H. S., Jung, T. W., Jeong, J. H., Lee, H. J., & Jung, K. O. (2023) · PPAR Research · doi:10.1155/2023/7550164 · Cited by 3
Yiaslas, T. A., Rogers-Soeder, T. S., Ono, G., Kitazono, R. E., & Sood, A. (2024) · American Journal of Lifestyle Medicine · doi:10.1177/15598276241267932 · Cited by 3
Implications of diet modification on sympathoinhibitory mechanisms and hypertension in obesity
Sfrantzis, K. D., How, J. M. Y., & Sartor, D. M. (2015) · Autonomic Neuroscience · doi:10.1016/j.autneu.2015.01.001 · Cited by 3
Sarno, F. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.6.2010.tde-09102010-183930 · Cited by 3
Modulation of Cardiac Autonomic Control in Children and Adolescents with Obesity
Khrisanapant, W., Sengmeuang, P., Pasurivong, O., & Kukongviriyapan, U. (2011) · Srinagarind Medical Journal (SMJ) - ศรีนครินทร์เวชสาร · Cited by 2
Mierswa, L., Schipke, J., & Mühlfeld, C. (2025) · Journal of Anatomy · doi:10.1111/joa.14221 · Cited by 2
Treatments for Hypertension in Type 2 Diabetes-Non-Pharmacological and Pharmacological Measurements
Masuo, K., & Gavin, W. (2011) · InTech eBooks · doi:10.5772/20685 · Cited by 2
Self-citationVascular Physiology and Pharmacology
Cherng, T. W., Jackson‐Weaver, O., & Kanagy, N. L. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00703-x · Cited by 2
Lottenberg, A. M. (2006) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 7
Exercise training reverse autonomic dysfunction and hypertension in rats fed with high-fat diet
de Sordi, C. C., Lemos, M. D. P., Marocolo, M., Chriguer, R. S., Mendes, E. L., da Mota, G. R., & Neto, O. B. (2017) · Motriz Revista de Educação Física · doi:10.1590/s1980-6574201700040004 · Cited by 2
Leptina, obesidad e hipertensión arterial
Cortada, J. V., & Coca, A. (2006) · Medicina Clínica · doi:10.1157/13088783 · Cited by 2
Autonomic Nervous System: Metabolic Function☆
Straznicky, N. E., Lambert, É., Lambert, G. W., & Esler, M. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.01819-8 · Cited by 1
Self-citationObesity-Hypertension Physiopathology and Treatment: A Forty-Year Retrospect
Owen, J., Morse, S., McLean, A., & Reisin, E. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-75310-2_15 · Cited by 1
Adiposity and Neurological Disorders: A Review
Haboubi, N. Y., Williams, H., & Al-Ansari, A. (2022) · EMJ Neurology · doi:10.33590/emjneurol/21-00177 · Cited by 1
Sympathetic vascular tone in human obesity
Correia, M. (2007) · doi:10.17077/etd.v54kf0if · Cited by 1
Autonomic response to oral glucose in those with metabolic syndrome
Jindal, R. D. (2009) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27750 · Cited by 1
Andersson, J. S. O. (2011) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
Association between autonomic regulation and cardiovascular risk factors in middle-aged subjects
Virtanen, R. (2007) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) · Cited by 1
Metadata
- Authors
- Straznicky, N. E., Lambert, E. A., Lambert, G. W., Masuo, K., Esler, M. D., & Nestel, P. J.
- Affiliations
- Baker Heart and Diabetes Institute (AU)
- Corresponding author
- Straznicky, Nora E.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-11
- Volume
- 90
- Issue
- 11
- Pages
- 5998-6005
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1976286624
- Cited by
- 227
- References
- 43
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 5 · 2023: 8 · 2022: 6 · 2021: 10 · 2020: 7 · 2019: 5 · 2018: 4 · 2017: 10 · 2016: 13 · 2015: 14 · 2014: 10 · 2013: 13 · 2012: 12
- FWCI
- 8.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Diabetes Australia Research Trust
- Diabetes Australia
- Heart Research Institute
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Keywords
- metabolic syndrome, dietary weight loss, hypocaloric diet, sympathetic activity, muscle sympathetic nerve activity, norepinephrine spillover, cardiac baroreflex sensitivity, insulin sensitivity, leptin, sodium restriction, DASH diet
- MeSH terms
- Aged, Cardiovascular Diseases, Female, Humans, Insulin Resistance, Male, Middle Aged, Muscles, Norepinephrine, Risk Factors, Sympathetic Nervous System, Weight Loss, Baroreflex, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review